中文 | English
Return
Total: 3074 , 1/308
Show Home Prev Next End page: GO
Author:(Rong-Rong XU)

1.Comparison of Legal Liability between US FDCA and Drug Administration Law of PRC

Rong XU ; Rong SHAO

China Pharmacy 1991;0(03):-

2.Enlightenment of American Drug Recall System on Drug Safety in China

Rong XU ; Rong SHAO

China Pharmacy 1991;0(06):-

3.The role of serum creatinine or Cystatin C in chronic kidney disease staging and prognosis assessment

Rong XU

Chinese Journal of Laboratory Medicine 2014;(6):415-419

4.Potency Determination of Lonicera Granule Based on Bacterial Inhibitory Activity

Rong XU

China Pharmacist 2016;19(2):369-371

5.Simultaneous Determination of 7 Flavonoids in Fengliaochangweikang Capsules and Optimization of Ex-traction Process for Total Flavones

Rong XU

China Pharmacist 2017;20(2):259-262

6.THE IMMUNOLOGIC EFFECT OF PARAOXON-TETANUS TOXOID ON RABBITS

Kangtai RONG ; Qinhui XU ;

Medical Journal of Chinese People's Liberation Army 1981;0(06):-

7.Current status and prospects of quantitative immunoassay technologies

Huizhong WANG ; Rong XU

Chinese Journal of Laboratory Medicine 2017;40(6):478-480

8.Clinical study on treatment of irritable bowel syndrome by massage combined with microecological regulators

Guochao XU ; Bing RONG

Chinese Journal of Biochemical Pharmaceutics 2017;37(8):418-419,422

9.Economic Analysis on Effects of TRIPS on the Conflict between Drug Patent Protection and Public Health

Jun XU ; Rong SHAO

China Pharmacy 2007;0(31):-

10.Effects of panax notoginseng saponins on expression of IL-10 and TNF-α in rats with focal cerebral ischemia-reperfusion

Xiaoming DING ; Rong XU

Journal of Regional Anatomy and Operative Surgery 2017;26(9):634-637

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3074 , 1/308 Show Home Prev Next End page: GO